← Back to Screener
InMode Ltd. Ordinary Shares (INMD)
Price$14.57
Favorite Metrics
Price vs S&P 500 (26W)-12.78%
Price vs S&P 500 (4W)-1.22%
Market Capitalization$928.21M
P/E Ratio (Annual)9.89x
All Metrics
P/CF (Annual)10.89x
Book Value / Share (Quarterly)$10.78
P/TBV (Annual)3.43x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-6.57%
Cash Flow / Share (Quarterly)$1.33
Price vs S&P 500 (YTD)-4.41%
Gross Margin (TTM)78.54%
Net Profit Margin (TTM)25.33%
EPS (TTM)$1.44
10-Day Avg Trading Volume0.81M
EPS Excl Extra (TTM)$1.44
Revenue Growth (5Y)12.45%
EPS (Annual)$1.43
ROI (Annual)13.73%
Gross Margin (Annual)78.54%
Net Profit Margin (5Y Avg)38.63%
Cash / Share (Quarterly)$8.76
P/E Basic Excl Extra (TTM)9.89x
Revenue Growth QoQ (YoY)6.13%
EPS Growth (5Y)9.99%
P/E Normalized (Annual)9.89x
ROA (Last FY)12.24%
Revenue Growth TTM (YoY)-6.16%
EBITD / Share (TTM)$1.32
ROE (5Y Avg)26.69%
Operating Margin (TTM)23.05%
Cash Flow / Share (Annual)$1.33
P/B Ratio1.36x
P/B Ratio (Quarterly)1.36x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.23x
ROA (TTM)12.88%
EPS Growth QoQ (YoY)-63.20%
EV / EBITDA (TTM)5.30x
EPS Incl Extra (Annual)$1.43
Current Ratio (Annual)9.88x
Quick Ratio (Quarterly)8.83x
3-Month Avg Trading Volume0.98M
52-Week Price Return-1.74%
EV / Free Cash Flow (Annual)5.42x
P/E Incl Extra (TTM)9.89x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$8.71
P/S Ratio (Annual)2.51x
Asset Turnover (Annual)0.48x
52-Week High$16.74
Operating Margin (5Y Avg)36.34%
EPS Excl Extra (Annual)$1.43
CapEx CAGR (5Y)14.22%
Tangible BV CAGR (5Y)95.43%
26-Week Price Return-4.03%
Quick Ratio (Annual)8.55x
13-Week Price Return4.34%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)9.88x
Enterprise Value$456.504
Revenue / Share Growth (5Y)18.26%
Asset Turnover (TTM)0.51x
Book Value / Share Growth (5Y)26.27%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.19x
Pretax Margin (Annual)29.78%
Cash / Share (Annual)$8.76
3-Month Return Std Dev41.69%
Gross Margin (5Y Avg)82.26%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)3.30%
EBITDA Interim CAGR (5Y)-5.97%
ROE (Last FY)13.73%
Net Interest Coverage (Annual)94.30x
EPS Basic Excl Extra (Annual)$1.43
P/FCF (TTM)11.01x
Receivables Turnover (TTM)9.28x
EV / Free Cash Flow (TTM)5.42x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$1.44
Receivables Turnover (Annual)9.28x
ROI (TTM)14.52%
P/S Ratio (TTM)2.51x
Pretax Margin (5Y Avg)40.32%
Revenue / Share (Annual)$5.66
Tangible BV / Share (Annual)$6.72
Forward P/E10.09x
Free OCF CAGR (5Y)1.38%
Price vs S&P 500 (52W)-36.84%
P/E Ratio (TTM)9.89x
EPS Growth TTM (YoY)-38.48%
Year-to-Date Return-0.27%
5-Day Price Return4.72%
EPS Normalized (Annual)$1.43
ROA (5Y Avg)23.56%
Net Profit Margin (Annual)25.33%
Month-to-Date Return7.09%
Cash Flow / Share (TTM)$2.11
EBITD / Share (Annual)$1.32
EPS Growth (3Y)-8.82%
Operating Margin (Annual)23.05%
P/CF (TTM)10.89x
ROI (5Y Avg)26.69%
P/E Excl Extra (TTM)9.89x
EPS Basic Excl Extra (TTM)$1.44
P/TBV (Quarterly)2.63x
P/B Ratio (Annual)1.36x
Inventory Turnover (TTM)1.19x
Pretax Margin (TTM)29.78%
Book Value / Share (Annual)$10.78
Price vs S&P 500 (13W)1.48%
Net Margin Growth (5Y)-6.99%
Beta2.04x
P/FCF (Annual)11.01x
Revenue / Share (TTM)$5.74
ROE (TTM)14.52%
52-Week Low$12.72
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.71
3.71
3.71
3.77
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
INMDInMode Ltd. Ordinary Shares | 2.51x | 12.45% | 78.54% | 23.05% | $14.57 |
MDTMedtronic plc | 3.13x | 3.01% | 65.16% | 17.00% | $85.00 |
MASIMasimo Corporation | 6.11x | 5.95% | 61.90% | 20.30% | $178.45 |
TMDXTransMedics Group, Inc. Common Stock | 6.56x | 88.21% | 59.92% | 17.93% | $113.13 |
LIVNLivaNova PLC Ordinary Shares | 2.59x | 8.24% | 68.04% | 14.09% | $65.81 |
ITGRInteger Holdings Corporation | 1.66x | 11.55% | 27.39% | 11.90% | $89.32 |
AXGNAxogen, Inc. Common Stock | 8.90x | 14.93% | 74.31% | -3.49% | $37.23 |
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $39.68 |
BLFSBioLife Solutions Inc. | 10.84x | 14.87% | 64.56% | -17.26% | $22.19 |
CBLLCeriBell, Inc. Common Stock | 8.96x | — | 87.89% | -65.57% | $21.13 |
CVCapsoVision, Inc. Common Stock | 22.10x | — | 52.92% | -188.25% | $6.01 |
About
InMode is a provider of energy-based treatment platforms for minimally invasive aesthetic and medical procedures. Its technology addresses facial and body contouring, medical aesthetics, and women's health across dermatology, plastic surgery, gynecology, and ophthalmology. The company generates substantially all revenue from the United States, with growing international sales in Europe and Asia.